How should an adult male be managed during the first five days after Aquablation, regarding catheter removal, pain control, antibiotics, hydration, activity restrictions, and warning signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Aquablation Management: First 5 Days

Catheter removal should occur on postoperative day 1 after a successful voiding trial, though patients with preoperative acute urinary retention have a 40% failure rate on initial trial and may benefit from delayed catheter removal. 1

Catheter Management

  • Remove the Foley catheter on postoperative day 1 for uncomplicated cases to minimize infection risk and patient discomfort. 2, 3

  • Patients with preoperative acute urinary retention require special consideration: 40% will fail their initial voiding trial compared to only 7.2% of patients without retention, suggesting these patients may benefit from a delayed trial without catheter. 1

  • Patients with chronic retention (postvoid residual >300 mL) have a 12.5% failure rate on initial voiding trial, intermediate between acute retention and no retention groups. 1

  • Monitor for urinary retention after catheter removal: Check postvoid residual if patient reports incomplete emptying or has difficulty voiding. 4

  • If voiding trial fails, replace catheter and retry in 24-48 hours; intermittent catheterization every 4-6 hours is an alternative if postvoid residual exceeds 100 mL. 5, 4

Bleeding Management and Monitoring

  • Bleeding is the primary concern in the first 5 days: Historical rates approached 8.3% with catheter traction as the predominant hemostatic technique, but systematic cautery loop hemostasis has reduced this to 1.4%. 6

  • Transfusion rates remain at 2.7% in real-world multi-center experience, with mean hemoglobin drop of 2.06 g/dL. 7, 8

  • Monitor for hematuria: Mild hematuria is expected initially but should progressively clear. Heavy bleeding with clots, inability to void, or hemodynamic instability requires immediate urologic consultation. 6

  • Maintain adequate hydration to prevent clot formation and facilitate bladder irrigation if needed. 5

Pain Control

  • Use multimodal analgesia: Acetaminophen and NSAIDs are first-line agents for postoperative pain control. 2

  • Avoid opioids if possible due to constipation risk and other complications, particularly in the setting of recent prostate surgery. 2

  • Bladder spasms are common: Anticholinergic agents may help with bladder spasm discomfort, though use cautiously to avoid urinary retention. 9, 4

  • Local measures: Cool packs applied to the perineum and topical anesthetic sprays can provide additional relief. 2

Antibiotic Management

  • Prophylactic antibiotics are not routinely continued beyond the perioperative period unless specific infection risk factors exist. 10, 9

  • Monitor for urinary tract infection: Fever, dysuria, or change in mental status should prompt urinalysis and culture. 5, 10

  • Indwelling catheters increase UTI risk significantly: This is another reason for early catheter removal on day 1. 4

  • If UTI develops, treat with appropriate antibiotics based on culture results. 10, 9

Activity Restrictions

  • Early mobilization is encouraged once hemodynamically stable to prevent complications including atelectasis, pneumonia, and venous thromboembolism. 5, 10

  • Avoid heavy lifting (>10 pounds) and strenuous activity for 2-4 weeks to minimize bleeding risk. 11

  • Sexual activity can resume at 1-2 weeks if patient can perform mild to moderate physical activity without symptoms, though this extends beyond the initial 5-day period. 11

  • Encourage regular walking to promote recovery and prevent complications from immobility. 5

Bowel Management

  • Implement bowel program immediately: Constipation increases intra-abdominal pressure and bleeding risk. 5, 4

  • Stool softeners should be started prophylactically rather than waiting for constipation to develop. 5, 4

  • Ensure adequate fluid and fiber intake to maintain soft stools. 4

  • Avoid straining with bowel movements: This can precipitate prostatic bleeding. 5

Warning Signs Requiring Immediate Attention

  • Heavy bleeding with clots or inability to void: May require catheter reinsertion, irrigation, or return to operating room. 6, 12

  • Fever >38.5°C (101.3°F): Evaluate for UTI, pneumonia, or other infection sources. 10, 9

  • Inability to void after catheter removal: Check postvoid residual and consider catheter replacement. 4, 1

  • Severe pain uncontrolled by oral medications: May indicate bladder spasm, clot retention, or other complication. 2

  • Signs of sepsis: Confusion, hypotension, tachycardia with fever require emergency evaluation. 10

Hospital Readmission Risk

  • Patients undergoing Aquablation have higher 30- and 90-day readmission rates compared to other BPH procedures, potentially related to the learning curve or application to larger prostate volumes. 12

  • Catheter reinsertion is more common in Aquablation patients at 30 and 90 days postoperatively compared to most other surgical BPH cohorts. 12

  • Close follow-up is essential: Schedule early postoperative visit within 1-2 weeks to assess voiding function and address complications. 2, 12

References

Guideline

repair of episiotomy and obstetrical perineal lacerations (first-fourth).

American Journal of Obstetrics and Gynecology, 2024

Guideline

Aquablation for Benign Prostatic Hyperplasia (BPH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Resuming Sexual Intercourse After Prostate Aquablation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.